CDKN2A and neoplasm: In parallel, analysis of circulating tumor cells (CTCs) showed that p16-positive CTCs were independently associated with reduced risk of disease progression and cancer-specific death, further supporting the role of viral-associated biomarkers in refining prognostic assessment [99].